Question explored with the scientific record
What supplements are really helpful?
The short version: most supplements sold for general health have thin evidence. A few help specific people in specific situations.
The evidence here is a sample of the literature, not the whole picture. But what it shows is that supplements are not general-purpose health boosters. They are targeted tools for people with a known deficiency or a clear risk.
Vitamin D is the best studied. The big trials are clear: for the general population, vitamin D alone does not prevent fractures, falls, cancer, or heart disease [1, 2]. The 2019 VITAL trial of 25,871 people found no reduction in cancer or cardiovascular events [1]. The 2018 Lancet meta-analysis of 44,790 people found no fracture reduction [1]. The only consistent benefit comes from daily vitamin D at 800-1,000 IU combined with calcium in older adults, which reduced hip fractures by about 16% [2, 3]. Even that benefit disappears with vitamin D alone, with intermittent high doses, or in people who are not deficient [3]. The 2022 meta-analysis of 32 trials found that daily 800-1,000 IU reduced fractures and falls, but only in people with baseline deficiency [3]. If your levels are normal, you are spending money for nothing.
Omega-3s are similar. Low-dose fish oil (1 gram daily) has no benefit for heart disease in any major trial [4]. The one exception is high-dose prescription EPA (icosapent ethyl, 4 grams daily) in people with high triglycerides already on a statin, which cut major cardiovascular events by 25% [4, 5]. That is a drug, not a fish oil capsule. The REDUCE-IT trial of 8,179 people showed a clear benefit, but the STRENGTH trial using a different high-dose omega-3 formulation found nothing [4]. The benefit appears specific to purified EPA at high doses, not to over-the-counter blends.
Probiotics have the best evidence for a narrow use: preventing and shortening antibiotic-associated diarrhea. The 2025 umbrella meta-analysis of 35 pediatric reviews found probiotics cut diarrhea incidence by about half [7]. A 2025 adult trial found faster resolution and fewer recurrences [6]. For H. pylori treatment, adding probiotics to antibiotics improved eradication by about 10% and reduced side effects [8]. But the effects are strain-specific, and the evidence for general gut health in healthy people is weak [9].
| Supplement | Who it helps | What it does | Evidence strength |
|---|---|---|---|
| Vitamin D + calcium | Older adults with deficiency | Reduces hip fractures ~16% | Moderate (Cochrane, 2022 meta) |
| Vitamin D alone | General population | No benefit for fractures, cancer, CVD | High (multiple large RCTs) |
| High-dose EPA (4g/day) | High triglycerides on statin | Reduces MACE ~25% | High (REDUCE-IT) |
| Low-dose fish oil | General population | No benefit for CVD | High (multiple large RCTs) |
| Probiotics | On antibiotics | Cuts diarrhea ~50% | Moderate (umbrella meta) |
| Probiotics | H. pylori treatment | Improves eradication ~10% | Moderate (40-trial meta) |
The pattern is consistent: supplements work best when correcting a known deficiency or addressing a specific risk. Taking them "just in case" when you are healthy and well-nourished is supported by almost no evidence from well-designed trials. The industry-funded studies that show broad benefits are contradicted by the large, independent trials.
My call: for most healthy people, no supplement is clearly helpful. The exceptions are targeted: vitamin D plus calcium for older adults at risk of deficiency, high-dose prescription EPA for high triglycerides on a statin, and probiotics during antibiotics. Everything else is marketing, not medicine. Confidence: high for the null findings in general populations, moderate for the specific benefits in targeted groups.
Sources used 9
-
Vitamin D supplementation –Is it the time to stop wasting money on vitamin D?
An editorial synthesizing recent meta-analyses and major randomized trials, arguing that vitamin D supplementation alone provides little or no benefit for fracture prevention, falls, or cancer/cardiovascular disease outcomes in the general population, with marginal or uncertain …
DOI: 10.33883/jms.v22i1.442 -
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
This systematic review evaluates the effectiveness of vitamin D and its analogues in preventing fractures among post-menopausal women and older men, concluding that while vitamin D alone is unlikely to prevent fractures, its combination with calcium may reduce the risk of hip an…
DOI: 10.1002/14651858.CD000227.pub4 -
Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis
In 32 RCTs, daily vitamin D 800-1,000 IU/day was associated with lower osteoporotic fracture and fall risk, and daily administration and vitamin D deficiency were associated with lower fall risk; overall fracture effects were null and falls were reduced.
DOI: 10.3803/enm.2021.1374 -
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease
This narrative review synthesizes randomized trial evidence on omega-3 fatty acids for prevention of atherosclerotic cardiovascular disease, highlighting limited benefit from low-dose formulations but a notable reduction in major adverse cardiovascular events with high-dose icos…
DOI: 10.1002/phar.2615 -
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
This paper recaps the REDUCE-IT trial, showing that high-dose icosapent ethyl (EPA) on statin therapy significantly reduces major cardiovascular events in patients with hypertriglyceridaemia, explores associated lipid/inflammatory changes and safety signals, and discusses implic…
DOI: 10.1093/eurheartj/suaa116 -
Effect of Probiotics on Gut Microbiome Restoration in Post-Antibiotic Diarrhea
Probiotic supplementation with Lactobacillus and Bifidobacterium at 10^10 CFU daily for 7 days accelerates diarrhea resolution and promotes gut microbiome restoration in adults after antibiotic use, reducing recurrence and hospital stay compared with standard care.
DOI: 10.61336/ejcp/25-12-556 -
Probiotics for pediatric diarrhea and constipation: an umbrella meta-analysis
An umbrella meta-analysis of 35 pediatric probiotic systematic reviews showing that probiotics reduce diarrhea incidence, prevalence, and duration and offer modest benefits for constipation, with high heterogeneity and strain-specific effects, highlighting the need for standardi…
DOI: 10.1186/s12887-025-06002-y -
Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects
A comprehensive meta-analysis of 40 randomized controlled trials (n = 5,792) showing that adding probiotics to standard Helicobacter pylori eradication therapy increases eradication rates by about 10% and reduces overall and specific antibiotic-related side effects, with longer …
DOI: 10.1016/j.micpath.2020.104403 -
The microbiota of healthy dogs demonstrates individualized responses to synbiotic supplementation in a randomized controlled trial
In healthy household dogs, a four-week multi-species synbiotic altered the gut microbiome modestly and transiently, with baseline microbial composition predicting response magnitude and a trend toward reduced diarrhea in the synbiotic group, though most health outcomes were not …
DOI: 10.1186/s42523-021-00098-0